Comparison of immediate therapeutic effects of 3% diquafosol and 2% rebamipide in dry eye disease: a prospective, randomized, paired-eye trial
Abstract Both diquafosol and rebamipide improve signs and symptoms of dry eye disease (DED), but no clinical study has directly compared their immediate effects. This study compared the 30-min therapeutic and mucin-secreting effects of 3% diquafosol (DQS) and 2% rebamipide (REB). In this prospective...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Portfolio
2026-05-01
|
| Edice: | Scientific Reports |
| Témata: | |
| On-line přístup: | https://doi.org/10.1038/s41598-026-53334-5 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|